Joanne Bowes

1.8k citations

17 papers · 1.3k indexed · 1 hit paper · h-index 12

Impact in

Computational Theory and Mathematics top 2%
- Computational Drug Discovery Methods
Biophysics top 5%

Papers in

Pathology and Forensic Medicine 7
- Cardiac Ischemia and Reperfusion 7
Biophysics 2
- Electron Spin Resonance Studies 2

Co-authors: Christoph Thiemermann Wolfgang Jarolimek Andrew J. Brown Steven Whitebread Gareth Waldron Arun Sridhar Jacques Hamon John R. Vane
Journals: British Journal of Pharmacology (4 papers)Toxicological Sciences (1 paper)Proceedings of the National Academy of Sciences (1 paper)Cardiovascular Research (1 paper)Nature Reviews Drug Discovery (1 paper)
Partner nations: United Kingdom Switzerland United States

In The Last Decade

Joanne Bowes

17 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling 2012 · 485 citations

Peers

Countries citing papers authored by Joanne Bowes

Since Specialization

Citations

This map shows the geographic impact of Joanne Bowes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Bowes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Bowes more than expected).

Fields of papers citing papers by Joanne Bowes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Bowes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Bowes. The network helps show where Joanne Bowes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joanne Bowes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joanne Bowes Line = papers co-authored together Joanne Bowes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Use of an Esophageal Heat Exchanger to Maintain Core Temperature during Burn Excisions and to Attenuate Pyrexia on the Burns Intensive Care Unit Case Reports in Anesthesiology ·David Williams, 美紀大平, Jiahuan Zhang, Raquel Ruiz Aparicio, Joanne Bowes, John Dingley	2016	17
2	Predicting changes in cardiac myocyte contractility during early drug discovery with in vitro assays Toxicology and Applied Pharmacology ·Michael J. Morton, Duncan Armstrong, Scott Landman, Joanna Sądel, C.E. Pollard, Joanne Bowes, J‐P Valentin	2014	10
3	Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Toxicological Sciences ·Amy Pointon, Alexander R. Harmer, Ian L. Dale, Najah Abi‐Gerges, Joanne Bowes, Christopher E. Pollard, Helen Garside	2014	81
4	Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes Toxicology in Vitro ·Helen Garside, 友子前原, J. F. Daniel Kelly, Alison J. Foster, Daniel Muthas, J. Gerry Kenna, Usha Warrior, Joanne Bowes, James E. Baumgartner	2013	74
5	Investigation of connexin 43 uncoupling and prolongation of the cardiacQRScomplex in preclinical and marketed drugs British Journal of Pharmacology ·Matthew Burnham, P. M. Sharpe, Colin Garner, Ruth Hughes, C.E. Pollard, Joanne Bowes	2013	15
6	Reducing safety-related drug attrition: the use of in vitro pharmacological profiling Nature Reviews Drug Discovery ·Joanne Bowes, Andrew J. Brown, Jacques Hamon, Wolfgang Jarolimek, Arun Sridhar, Gareth Waldron, Steven Whitebread Hit paper breakdown →	2012	485
7	Mechanistic understanding of drug-induced mitochondrial toxicity using isolated mitochondrial complex assays Journal of Pharmacological and Toxicological Methods ·Emma Low, Matthew Burnham, Helen Garside, Jean‐Pierre Valentin, Joanne Bowes	2012	1
8	Rational design of an in vitro safety profiling panel to reduce undesired secondary pharmacology of drug candidates Journal of Pharmacological and Toxicological Methods ·Steven Whitebread, Joanne Bowes, Andrew J. Brown, Jacques Hamon, Wolfgang Jarolimek, Gareth Waldron, Arun Sridhar	2011	1
9	In vitro pharmacological profiles of kinase inhibitors: Comparison with other pharmaceuticals Journal of Pharmacological and Toxicological Methods ·Richard Luke, B. Boimska, Mate Nemes, Ed Griffen, Neil J. Hales, Jason G. Kettle, Andrew P. Thomas, Joanne Bowes, Jean‐Pierre Valentin, Andy Barker	2009	1
10	Using variance tracking to improve outcomes and reduce costs Dimensions of Critical Care Nursing ·Linda M. Benson, Joanne Bowes, Somayyeh Hassanabadi, Lars König, Mohanasundari Marimuthu, B.C. Benson Hsiung, Francisco Romerito de Goes Lima, Sepideh motevali, Lidia kartikasa, D. Rousseau, Antoine Moussalem, ماندانا توکلی, J.A. Verbruggen	2001	4
11	Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion Free Radical Biology and Medicine ·Michelle C. McDonald, Kai Zacharowski, Joanne Bowes, Salvatore Cuzzocrea, Christoph Thiemermann	1999	105
12	An inhibitor of poly (ADP‐ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart British Journal of Pharmacology ·John C. Docherty, Elsiane Lara Gomes Freire de Sá, Jocelyn A. Silvester, Joanne Bowes, Christoph Thiemermann	1999	56
13	Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress Cardiovascular Research ·Joanne Bowes	1999	65
14	Inhibitors of the activity of poly (ADP‐ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts British Journal of Pharmacology ·Joanne Bowes, 川本竜彦, Christoph Thiemermann	1998	62
15	Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig European Journal of Pharmacology ·Joanne Bowes, Hartmut Ruetten, Piero A. Martorana, Frederick Sterling Pierce, Christoph Thiemermann	1998	36
16	Effects of inhibitors of the activity of poly (ADP‐ribose) synthetase on the liver injury caused by ischaemia‐reperfusion: a comparison with radical scavengers British Journal of Pharmacology ·Joanne Bowes, Christoph Thiemermann	1998	37
17	Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia–reperfusion injury in the heart and skeletal muscle Proceedings of the National Academy of Sciences ·Christoph Thiemermann, Joanne Bowes, Fiona Myint, John R. Vane	1997	265

About Joanne Bowes

Joanne Bowes is a scholar working on Pathology and Forensic Medicine, Biophysics, Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine and Oncology, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (7 papers), Cardiac electrophysiology and arrhythmias (7 papers), Ion channel regulation and function (4 papers), PARP inhibition in cancer therapy (4 papers), Electron Spin Resonance Studies (2 papers), Clinical practice guidelines implementation (1 paper), Advanced Breast Cancer Therapies (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). The work is most often cited by research in Computational Theory and Mathematics (221 citations), Biophysics (77 citations), Pathology and Forensic Medicine (234 citations), Pharmacology (113 citations) and Cardiology and Cardiovascular Medicine (289 citations). Joanne Bowes has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Christoph Thiemermann, Wolfgang Jarolimek, Andrew J. Brown, Steven Whitebread, Gareth Waldron, Arun Sridhar, Jacques Hamon, John R. Vane, Fiona Myint and Salvatore Cuzzocrea. Their work appears in journals such as British Journal of Pharmacology, Toxicological Sciences, Proceedings of the National Academy of Sciences, Cardiovascular Research and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact